158 related articles for article (PubMed ID: 38496158)
1. High Diagnostic Accuracy of Thyroid-Stimulating Hormone (TSH) Receptor Antibodies in Distinguishing Graves' Disease and Subacute Thyrotoxicosis in the Indian Population.
Naga Nitin LT; Lakkundi S; S L SR; Shanthaiah DM; Datta SG; Annavarapu U; Sarathi V
Cureus; 2024 Feb; 16(2):e54303. PubMed ID: 38496158
[TBL] [Abstract][Full Text] [Related]
2. Differentiating Graves' disease from subacute thyroiditis using ratio of serum free triiodothyronine to free thyroxine.
Sriphrapradang C; Bhasipol A
Ann Med Surg (Lond); 2016 Sep; 10():69-72. PubMed ID: 27570620
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.
Scappaticcio L; Trimboli P; Keller F; Imperiali M; Piccardo A; Giovanella L
Clin Endocrinol (Oxf); 2020 Feb; 92(2):169-178. PubMed ID: 31742747
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of the 2nd generation assay for anti-TSH receptor antibodies to differentiate relapse of Graves' thyrotoxicosis from development of painless thyroiditis after antithyroid drug treatment for Graves' disease.
Izumi Y; Takeoka K; Amino N
Endocr J; 2005 Aug; 52(4):493-7. PubMed ID: 16127219
[TBL] [Abstract][Full Text] [Related]
5. Simple and practical parameters for differentiation between destruction-induced thyrotoxicosis and Graves' thyrotoxicosis.
Izumi Y; Hidaka Y; Tada H; Takano T; Kashiwai T; Tatsumi KI; Ichihara K; Amino N
Clin Endocrinol (Oxf); 2002 Jul; 57(1):51-8. PubMed ID: 12100069
[TBL] [Abstract][Full Text] [Related]
6. Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves' disease.
Ota H; Amino N; Morita S; Kobayashi K; Kubota S; Fukata S; Kamiyama N; Miyauchi A
Clin Endocrinol (Oxf); 2007 Jul; 67(1):41-5. PubMed ID: 17437515
[TBL] [Abstract][Full Text] [Related]
7. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of classification of Graves' disease according to the characteristics of TSH receptor antibodies.
Kim WB; Chung HK; Park YJ; Park DJ; Lee HK; Cho BY
Korean J Intern Med; 2001 Sep; 16(3):187-200. PubMed ID: 11769578
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Utility of Mean Peak Systolic Velocity of Superior Thyroid Artery in Differentiating Graves' Disease from Thyroiditis.
Sarangi PK; Parida S; Mangaraj S; Mohanty BK; Mohanty J; Swain BM
Indian J Radiol Imaging; 2021 Apr; 31(2):311-317. PubMed ID: 34556913
[No Abstract] [Full Text] [Related]
10. A long-term follow-up study of patients with non-toxic diffuse goitre in Japan.
Hara T; Tamai H; Mukuta T; Fukata S; Kuma K; Nakagawa T
Clin Endocrinol (Oxf); 1993 Nov; 39(5):541-6. PubMed ID: 8252742
[TBL] [Abstract][Full Text] [Related]
11. Ratio of serum free triiodothyronine to free thyroxine in Graves' hyperthyroidism and thyrotoxicosis caused by painless thyroiditis.
Yoshimura Noh J; Momotani N; Fukada S; Ito K; Miyauchi A; Amino N
Endocr J; 2005 Oct; 52(5):537-42. PubMed ID: 16284430
[TBL] [Abstract][Full Text] [Related]
12. Serum Ratio of Free Triiodothyronine to Thyroid-Stimulating Hormone: A Novel Index for Distinguishing Graves' Disease From Autoimmune Thyroiditis.
Wu Z; Zhu Y; Zhang M; Wang C; Zhou L; Liu W; Yang W; Li M; Zhang S; Ren Q; Han X; Ji L
Front Endocrinol (Lausanne); 2020; 11():620407. PubMed ID: 33488527
[TBL] [Abstract][Full Text] [Related]
13. Elevated Graves' Disease-Specific Thyroid-Stimulating Immunoglobulin and Thyroid Stimulating Hormone Receptor Antibody in a Patient With Subacute Thyroiditis.
Alvin Mathew A; Papaly R; Maliakal A; Chandra L; Antony MA
Cureus; 2021 Nov; 13(11):e19448. PubMed ID: 34912598
[TBL] [Abstract][Full Text] [Related]
14. Graves Disease Following Subacute Thyroiditis in a Chinese Man.
Al-Bacha S; Lahiri SW
AACE Clin Case Rep; 2022; 8(2):73-77. PubMed ID: 35415228
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Utility of a New Assay for Thyroid Stimulating Immunoglobulins in Graves' Disease and Thyroid Eye Disease.
Stan MN; Algeciras-Schimnich A; Murthy V; Thapa P; Araki N
Thyroid; 2022 Feb; 32(2):170-176. PubMed ID: 34714163
[No Abstract] [Full Text] [Related]
16. Free triiodothyronine to free thyroxine ratio in the differential diagnosis of thyrotoxicosis and hyperthyroidism: A retrospective study.
Tura Bahadır Ç; Yılmaz M; Kılıçkan E
Int J Clin Pract; 2021 May; 75(5):e14003. PubMed ID: 33403716
[TBL] [Abstract][Full Text] [Related]
17. The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease.
Kim WB; Chung HK; Park YJ; Park DJ; Tahara K; Kohn LD; Cho BY
Thyroid; 2000 Jul; 10(7):579-86. PubMed ID: 10958310
[TBL] [Abstract][Full Text] [Related]
18. Measurement of anti-TSH receptor antibodies: what is the correct cut-off value?
Smit MA; van Kinschot CMJ; van der Linden J; van Noord C; Kos S
Neth J Med; 2020 Mar; 78(2):55-63. PubMed ID: 32332174
[TBL] [Abstract][Full Text] [Related]
19. Prediction of post-partum Graves' thyrotoxicosis by measurement of thyroid stimulating antibody in early pregnancy.
Hidaka Y; Tamaki H; Iwatani Y; Tada H; Mitsuda N; Amino N
Clin Endocrinol (Oxf); 1994 Jul; 41(1):15-20. PubMed ID: 7914152
[TBL] [Abstract][Full Text] [Related]
20. A novel bioreporter assay for thyrotropin receptor antibodies using a chimeric thyrotropin receptor (mc4) is more useful in differentiation of Graves' disease from painless thyroiditis than conventional thyrotropin-stimulating antibody assay using porcine thyroid cells.
Kamijo K; Murayama H; Uzu T; Togashi K; Kahaly GJ
Thyroid; 2010 Aug; 20(8):851-6. PubMed ID: 20615137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
